Selective inhibition of BMK1 suppresses tumor growth
2010-09-13
(Press-News.org) A study describing a newly developed pharmacological inhibitor is providing detailed insight into how an enzyme that has been implicated in multiple human malignancies regulates a known tumor suppressor. The research, published by Cell Press in the September 14th issue of the journal Cancer Cell, may have broad application for treating human cancers.
Mitogen-activated protein kinases (MAPKs) are enzymes that regulate multiple cellular activities, including proliferation and cell survival. Mutations in MAPK signaling pathways have been shown to play a significant role in many types of cancer. Of the four different MAPKs that have been identified in mammalian cells, ERK1/2 and BMK1 exhibit significant structural similarity. In fact, recent research has shown that some pharmacological compounds which have been considered to be specific inhibitors of ERK1/2, also interfere with the lesser known BMK1.
"It is critical that results using the common MAPK inhibitors be reevaluated using more specific inhibitors of the BMK1 and ERK1/2 cascades. However, so far there has been no specific small-molecule inhibitor of BMK1 that is effective both in cells and animals," explains senior study author, Dr. Jiing-Dwan Lee, from The Scripps Research Institute in La Jolla, California. "More importantly, the lack of this kind of BMK1 inhibitor has hampered the understanding of the physiological/pathological roles of BMK1."
Dr. Lee and colleagues discovered that promyelocytic leukemia protein (PML), which is a known tumor suppressor, is inhibited by BMK1. "Previous reports had implicated ERK1/2 in the regulation of PML," says Dr. Lee. "However, in our study we found that that BMK1 interacts with PML and suppresses its antitumor actions." To further investigate the BMK1-PML interaction, the researchers developed a compound called XMD8-92 that was remarkably selective at inhibiting BMK1.
Treatment with XMD8-92 blocked tumor cell proliferation and significantly inhibited tumor growth in mice. Importantly XMD8-92 had no obvious negative effects on the animals. "These results demonstrate that the BMK1 pathway can be blocked effectively by a small-molecule inhibitor without apparent adverse effects and, more importantly, BMK1 inhibition is a very effective way to prevent cancer development in animals," concludes Dr. Lee. "As BMK1 is expressed in most tumor cells, our results suggest that cancer therapies targeting BMK1 may be useful for treating diverse types of human tumors."
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-09-13
People who play action video games are known for their fast reaction times compared to those who don't play the games. And it isn't that they are just "trigger happy," according to researchers who report their findings in the September 14th issue of Current Biology, a Cell Press publication.
Rather, gamers are better at making quick and accurate decisions based on evidence extracted from their surroundings (a skill known as probabilistic inference). That appears to explain why video game-playing skills translate into broad improvements in many kinds of tasks, regardless ...
2010-09-13
Performing early surgery on elderly hip fracture patients reduces the risk of death by 19%, found a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj092220.pdf.
Hip fractures are associated with a mortality rate of 14 to 36% in the year following the fracture and can negatively affect a patient's independence and quality of life. Current guidelines recommend surgery within 24 hours of the break, although some physicians who favour delays believe it provides more time to prepare the patient and can decrease ...
2010-09-13
Cryotherapy with liquid nitrogen is the most effective method to remove common warts, found a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj092194.pdf.
The study, a randomized controlled trial, looked at 240 participants aged 4 to 79 in the Netherlands. The patients were assigned to three groups: cryotherapy with liquid nitrogen every two weeks, daily self-application of salicylic acid or a wait-and-see approach.
Warts are a common childhood complaint, present in up to one-third of primary school ...
2010-09-13
Health care professionals need sensitivity when delivering the news of a patient's imminent death, states an editorial in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj101201.pdf.
Rather than delegate end of life discussions to inexperienced members of medical teams, these should be delivered by experienced professionals with a network of colleagues who can help in communication and decision-making.
"Without investments in training for all health care professionals and ongoing support for palliative care, we will ...
2010-09-13
Hutchinson-Gilford Progeria Syndrome (HGPS or progeria) is a rare genetic disease that causes young children to develop symptoms associated with advanced age, such as baldness, wrinkles, osteoporosis and cardiovascular disease. Now, a study published by Cell Press in the September 14th issue of the journal Developmental Cell uses a mouse model to shed light on progeria, and perhaps also on the normal aging process.
Progeria is caused by a mutation in the gene for lamin A that leads to production of "progerin", a truncated form of the lamin A protein that causes the cell ...
2010-09-13
African Americans with muscular dystrophy die 10 to 12 years younger than their white counterparts, according to research published in the Sept. 14 issue of Neurology, the medical journal of the American Academy of Neurology.
The black-white mortality gap, which was calculated on the basis of 20 years of data, is among the largest ever observed in the annals of research into racial disparities in health care, say Dr. Nicte Mejia and Dr. Rachel Nardin, co-authors of the editorial. "Furthermore," they write, "white patients with MD [muscular dystrophy] enjoy increasing ...
2010-09-13
Smokeless tobacco products should not be used as an alternative to cigarettes or for smoking cessation due to the risk of addiction and return to smoking, according to an American Heart Association policy statement.
Smokeless tobacco products such as dry and moist snuff as well as chewing tobacco may also increase the risk of fatal heart attack, fatal stroke and certain cancers, according to the statement published online in Circulation: Journal of the American Heart Association.
"No tobacco product is safe to consume," said Mariann Piano, Ph.D., lead writer of the ...
2010-09-13
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease that results in chronic kidney failure. Although the genes responsible for ADPKD have been identified (PKD1, PKD2), relatively little is known about how mutations in these genes promote cyst growth molecularly. In this paper, scientists at Children's Hospital in Boston, lead by Jordon Kreidberg, investigated the signaling pathways that go awry in the disease using mouse kidney epithelial cells in which Pkd1 was genetically deleted. They found that the protein c-Met was hyperactive in Pkd1-deficient ...
2010-09-13
Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy. Thus far, however, JAK2 inhibition strategies have had limited efficacy and have been accompanied by significant toxicity. In this paper, Ross Levine and his group at the Memorial Sloane Kettering ...
2010-09-13
EDITOR'S PICK
Hi-JAK-ing Cancer by Inhibiting Jak2
Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy. Thus far, however, JAK2 inhibition strategies have had limited efficacy and have been accompanied by significant toxicity. In this paper, Ross ...
LAST 30 PRESS RELEASES:
[Press-News.org] Selective inhibition of BMK1 suppresses tumor growth